📰 Euronext News
Page 8 - Euronext News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Euronext. Real-time updates on events, politics, business and more.
May 28, 2024
BARCELONA, Spain, May 28, 2024 /PRNewswire/ -- Sanofi is all in on AI and wants to become the first...
May 28, 2024
Chicago wheat futures jumped 3% on Tuesday to a new 10-month high before paring gains as the market reacted to reduced harvest projections and shifting rain forecasts for top exporter Russia. Corn... -May 28, 2024 at 07:42 am EDT - MarketScreener
May 28, 2024
Amsterdam and Astana, 28 May 2024: VEON Ltd. , a global digital operator that provides converged connectivity and online services, announces that it has signed an agreement for the sale of its...
May 28, 2024
Parallel Advisors LLC boosted its stake in shares of Invesco S&P 500 Equal Weight ETF (NYSEARCA:RSP – Free Report) by 2.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 37,150 shares of the company’s stock after acquiring an additional 870 shares during the […]
May 28, 2024
Approbation de distribution des dividendes 28 May 2024 18:41 CEST Subscribe ...
May 28, 2024
Amsterdam and Astana, 28 May 2024: VEON Ltd. (NASDAQ:VEON, Euronext Amsterdam: VEON)), a global digital operator that provides converged connectivity and online services, announces that it has signed an agreement
May 28, 2024
Repurchase of Shares Amsterdam, the Netherlands - Flow Traders Ltd. (Euronext: FLOW) has repurchased 44,443 of its own shares in the period from 20 May 2024 up to and including 22 May 2024 at an average
May 28, 2024
Edmond DE Rothschild Holding S.A. lowered its stake in Invesco S&P 500 Equal Weight ETF (NYSEARCA:RSP – Free Report) by 47.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 78,469 shares of the company’s stock after selling 69,734 shares during the period. Edmond DE […]
May 28, 2024
ERHS II - Ordinary & Extraordinary General Meeting of Shareholders 28 May 2024 21:03 CEST Subscribe ...
May 28, 2024
New data from the completed dose escalation part and ongoing expansion part of Study 1100, an ongoing US Phase 1 study evaluating NBTXR3 followed by anti-PD-1 in patients with recurrent or metastatic...